ARTICLE | Company News
Biomira, Tosoh Corp. deal
May 27, 1997 7:00 AM UTC
Tosoh exercised its option to license BIOMF's B27.29 antibody against the CA27.29 antigen for breast cancer diagnosis. Tosoh will incorporate the antibody in its breast cancer immunoassays. BIOMF wil...